Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.840
+0.020 (0.71%)
At close: Apr 20, 2026, 4:00 PM EDT
2.850
+0.010 (0.35%)
Pre-market: Apr 21, 2026, 5:52 AM EDT
Acumen Pharmaceuticals Employees
Acumen Pharmaceuticals had 61 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
61
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,989,098
Market Cap
205.08M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 61 | 0 | - | 60 | 1 |
| Dec 31, 2024 | 61 | 9 | 17.31% | 61 | 0 |
| Dec 31, 2023 | 52 | 12 | 30.00% | 51 | 1 |
| Dec 31, 2022 | 40 | 23 | 135.29% | 39 | 1 |
| Dec 31, 2021 | 17 | 10 | 142.86% | 14 | 3 |
| Mar 31, 2021 | 7 | - | - | 7 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| ProQR Therapeutics | 187 |
| Tonix Pharmaceuticals Holding | 142 |
| Heron Therapeutics | 128 |
| Precision BioSciences | 68 |
| Korro Bio | 58 |
| Enlivex | 34 |
| Whitehawk Therapeutics | 23 |
ABOS News
- 25 days ago - Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights - GlobeNewsWire
- 4 weeks ago - Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026 - GlobeNewsWire
- 5 weeks ago - Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio - GlobeNewsWire
- 5 weeks ago - Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum - GlobeNewsWire
- 8 months ago - Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 8 months ago - Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 9 months ago - Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025 - GlobeNewsWire
- 9 months ago - JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform - Business Wire